Chembio Diagnostics, Inc.(CEMI)

Description: Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.

---

Keywords: Medicine Infectious Diseases Immunology Immune System Antibodies Public Health Technology Products Antibody HIV Medical Test Diagnostic Tests Multiplex HIV/Aids Diagnostic Systems Ortho Clinical Diagnostics Retail Establishments Syphilis Diagnosis Of Hiv/Aids Medford

---

Home Page: chembio.com

CEMI Technical Analysis

555 Wireless Boulevard
Hauppauge, NY 11788
United States
Phone: 631 924 1135

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)